Francis Leonard's most recent trade in NovoCure Ltd was a trade of 833 Ordinary Shares done at an average price of $15.1 . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Francis Leonard | EVP, Pres., Novocure Oncology | Grant, award, or other acquisition of securities at price $ 15.13 per share. | 30 Jun 2025 | 833 | 348,711 (0%) | 0% | 15.1 | 12,603 | Ordinary Shares |
| NovoCure Ltd | Francis Leonard | EVP, Pres., Novocure Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 179,426 | 347,878 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Francis Leonard | EVP, Pres., Novocure Oncology | Sale of securities on an exchange or to another person at price $ 17.22 per share. | 02 Jun 2025 | 21,717 | 176,931 (0%) | 0% | 17.2 | 373,958 | Ordinary Shares |
| NovoCure Ltd | Francis Leonard | EVP, Pres., Novocure Oncology | Sale of securities on an exchange or to another person at price $ 17.99 per share. | 02 Jun 2025 | 6,600 | 170,331 (0%) | 0% | 18.0 | 118,733 | Ordinary Shares |
| NovoCure Ltd | Francis Leonard | EVP, Pres., Novocure Oncology | Sale of securities on an exchange or to another person at price $ 19.01 per share. | 02 Jun 2025 | 1,879 | 168,452 (0%) | 0% | 19.0 | 35,722 | Ordinary Shares |
| NovoCure Ltd | Francis Leonard | EVP, Pres., Novocure Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 81,499 | 81,499 | - | - | Stock Options (Right to buy) | |
| NovoCure Ltd | Francis Leonard | EVP, Pres., Novocure Oncology | Grant, award, or other acquisition of securities at price $ 18.19 per share. | 04 Mar 2025 | 54,975 | 198,648 (0%) | 0% | 18.2 | 999,995 | Ordinary Shares |
| NovoCure Ltd | Francis Leonard | EVP, Pres., Novocure Oncology | Sale of securities on an exchange or to another person at price $ 18.54 per share. | 03 Mar 2025 | 2,527 | 143,673 (0%) | 0% | 18.5 | 46,841 | Ordinary Shares |
| NovoCure Ltd | Francis Leonard | EVP, Pres., Novocure Oncology | Sale of securities on an exchange or to another person at price $ 19.92 per share. | 27 Feb 2025 | 10,277 | 150,959 (0%) | 0% | 19.9 | 204,737 | Ordinary Shares |
| NovoCure Ltd | Francis Leonard | EVP, Pres., Novocure Oncology | Sale of securities on an exchange or to another person at price $ 18.28 per share. | 27 Feb 2025 | 2,770 | 146,200 (0%) | 0% | 18.3 | 50,648 | Ordinary Shares |
| NovoCure Ltd | Francis Leonard | EVP, Pres., Novocure Oncology | Sale of securities on an exchange or to another person at price $ 20.55 per share. | 27 Feb 2025 | 1,989 | 148,970 (0%) | 0% | 20.5 | 40,872 | Ordinary Shares |
| NovoCure Ltd | Francis Leonard | EVP, Pres., Novocure Oncology | Sale of securities on an exchange or to another person at price $ 15.94 per share. | 01 Nov 2024 | 598 | 161,236 (0%) | 0% | 15.9 | 9,531 | Ordinary Shares |
| NovoCure Ltd | Francis Leonard | EVP, Pres., Novocure Oncology | Grant, award, or other acquisition of securities at price $ 12.24 per share. | 28 Jun 2024 | 1,736 | 161,834 (0%) | 0% | 12.2 | 21,249 | Ordinary Shares |